Skip to main content

Table 1 Characteristics of Studies Included in Meta-analysis

From: How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis

Study

Year

Location

Indomethacin (n)

Placebo (n)

Number of PEPs (n)

Intervention

Definition of PEP

Montaño Loza et al.

2007

Mexico

75

75

16

100 mg indomethacin 2 h before ERCP

Pain, Amylase > 3 times

Sotoudehmane sh et al.

2007

Iran-Single centre

245

245

22

100 mg indomethacin immediately before ERCP

Pain, Amylase > 3 times admission

Elmunzer et al.

2012

US-Multicentre

295

307

79

two 50-mg indomethacin after ERCP

Pain, Amylase > 3 times admission > 2 nigh

döbrönte et al.

2014

Hungary-Multicentre

347

318

42

100 mg indomethacin 10–15 min before ERCP

Pain, Amylase > 3 times a prolognation of admission, CT/MRI

Andrade-Dávila et al.

2015

Mexico

82

84

21

100 mg indomenthacin after ERCP

Pain, Amylase > 3 times admission > 2 nigh

Patai et al.

2015

USA-Single centre

270

296

55

100 mg indomethacin within 1 before ERCP

Pain, Amylase > 3 times

Levenick et al.

2016

USA-Single centre

223

226

27

two 50-mg indomethacin during ERCP

Pain, Amylase > 3 times admission > 2 nigh